Heron Therapeutics | Ativos

Assets Alterar Data
ALKERMES USD 2.28B 92.05M 2023-09
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
Amarin USD 839.03M 20.99M 2023-09
ANI Pharmaceuticals USD 904.42M 14.51M 2023-12
Arrowhead Research USD 626.29M 139.27M 2023-12
Eisai JPY 1.33T 28.9B 2023-09
GlaxoSmithKline GBP 60.86B 1.4B 2023-09
Insmed USD 1.33B 4.96M 2023-12
Ligand Pharmaceuticals USD 787.22M 17.99M 2023-12
Merck USD 106.73B 2.26B 2023-09
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
Pacira USD 1.57B 39.92M 2023-12
Regeneron Pharmaceuticals USD 33.08B 916.9M 2023-12
Roche Holding CHF 84.37B 3.78B 2023-06
Ultragenyx Pharmaceutical USD 1.49B 252.87M 2023-12
Veracyte USD 1.11B 10.04M 2023-12
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09



Heron Therapeutics Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.